Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,982 | 27,193 | 18,722 | 31,816 | 32,547 |
| Depreciation Amortization | 67,066 | 5,991 | 5,539 | 4,290 | 3,734 |
| Income taxes - deferred | -3,543 | 794 | -1,817 | -1,198 | -65 |
| Accounts receivable | 5,855 | -1,839 | 2,914 | 2,674 | -6,201 |
| Accounts payable and accrued liabilities | 822 | 767 | -1,671 | 3,890 | -5,059 |
| Other Working Capital | -12,948 | -6,668 | -3,200 | -2,357 | -15,866 |
| Other Operating Activity | -20,205 | 10,767 | 14,431 | 1,697 | 15,358 |
| Operating Cash Flow | $13,065 | $37,005 | $34,918 | $40,812 | $24,448 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 24,965 | 42,518 | -45,601 | -3,500 | 7,251 |
| PPE Investments | -1,628 | -2,827 | -4,656 | -8,980 | -14,014 |
| Net Acquisitions | -94,601 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-71,264 | $39,691 | $-50,257 | $-12,480 | $-6,763 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 50,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -50,558 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 1,524 | 22,151 | 2,886 | 314 | 1,007 |
| Common Stock Repurchased | N/A | -30,000 | -30,000 | N/A | -25,000 |
| Other Financing Activity | -4,740 | -293 | -1,790 | 0 | 0 |
| Financing Cash Flow | $-3,774 | $-8,142 | $-28,904 | $314 | $-23,993 |
| Exchange Rate Effect | 327 | -133 | 29 | 349 | -138 |
| Beginning Cash Position | 157,463 | 89,042 | 133,256 | 104,261 | 110,707 |
| End Cash Position | 95,817 | 157,463 | 89,042 | 133,256 | 104,261 |
| Net Cash Flow | $-61,646 | $68,421 | $-44,214 | $28,995 | $-6,446 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,065 | 37,005 | 34,918 | 40,812 | 24,448 |
| Capital Expenditure | -1,628 | -2,827 | -4,656 | -8,980 | -14,014 |
| Free Cash Flow | 11,437 | 34,178 | 30,262 | 31,832 | 10,434 |